Relistor

Valeant wins FDA oral Relistor approval and $1B sales potential

Troubled Canadian specialty pharma company Valeant has won U.S. approval for a new oral formulation of the previously injectable-only med Relistor for certain forms of constipation in what could push the drug into blockbuster territory.

Ben Adams Jul 20, 2016 5:06am